• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

OctoPlus NV

D8C:GR

Ticker Delisted

Snapshot for OctoPlus NV (D8C)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for D8C

No chart data available.
  • D8C:GR
  • 1M
  • 1Y
0.000
Interactive D8C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for D8C

Current P/E Ratio (ttm) -
Estimated P/E(12/2012) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2012) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for D8C

No data available

Company Profile & Key Executives for D8C

OctoPlus NV develops pharmaceutical products that are based on proprietary drug delivery technologies. The Company strives to provide products that have fewer side effects, increased patient convenience, and better efficacy than existing products. Octoplus further provides drug formulation and manufacturing services to biotechnology and pharmaceutical companies.

Gustaaf Van Reet "Staf"Chairman-Supervisory BoardJan Hendrik EgbertsChief Executive Officer
Susan SwarteChief Financial OfficerGerben MoolhuizenChief Business Officer
More Company Profile & Key Executives for D8C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil